Morgan Stanley also reaffirmed an Overweight rating with a price target of $1,133, following a new agreement with Cigna/Evernorth to cap patient copays for Eli Lilly’s Zepbound.

Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors. The Cigna Group (NYSE:CI)’s Evernorth ...

CVS Health (NYSE:CVS) and Cigna (NYSE:CI), which operate some of the largest pharmacy benefit managers (PBMs) in the U.S., have sued Arkansas, seeking to block a state law that is set to ban PBMs ...

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated ...

Jefferson Health says it has reached a new agreement with Cigna, ensuring that all Jefferson Health hospitals, physician practices, and providers remain in-network, according to a news release ...

Earlier this month, Novo and Lilly partnered with Cigna’s health services subsidiary to discount GLP-1s for employer and health plan clients, and cap patients’ copays for the weight loss ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a ...

DiveWire guarantees visibility for your news announcements through instant distribution to Healthcare Dive’s audience and its 141,500 newsletter subscribers for 21 days.